Secondary outcomes include serum biomarkers of SCI osteoporosis ( sclerostin , P1NP and - CTX ) , markers of immune function ( IL-6 , IL-10 , FGF2 , INF - , TNF - ) , neurological function , body composition , depression and quality of life .